These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11191886)

  • 1. Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS.
    Wolkenstein P; Loriot MA; Aractingi S; Cabelguenne A; Beaune P; Chosidow O
    Pharmacogenetics; 2000 Dec; 10(9):821-8. PubMed ID: 11191886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.
    O'Neil WM; MacArthur RD; Farrough MJ; Doll MA; Fretland AJ; Hein DW; Crane LR; Svensson CK
    J Clin Pharmacol; 2002 Jun; 42(6):613-9. PubMed ID: 12043950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study.
    Rodrigo L; Alvarez V; Rodriguez M; Pérez R; Alvarez R; Coto E
    Scand J Gastroenterol; 1999 Mar; 34(3):303-7. PubMed ID: 10232877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk.
    Wikman H; Piirilä P; Rosenberg C; Luukkonen R; Kääriä K; Nordman H; Norppa H; Vainio H; Hirvonen A
    Pharmacogenetics; 2002 Apr; 12(3):227-33. PubMed ID: 11927838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
    Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
    Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
    Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
    Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
    J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.
    van der Hel OL; Peeters PH; Hein DW; Doll MA; Grobbee DE; Kromhout D; Bueno de Mesquita HB
    Pharmacogenetics; 2003 Jul; 13(7):399-407. PubMed ID: 12835615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors.
    Procopciuc LM; Osian G
    Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
    Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
    Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.
    Rieder MJ; Shear NH; Kanee A; Tang BK; Spielberg SP
    Clin Pharmacol Ther; 1991 Jan; 49(1):13-7. PubMed ID: 1988235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.
    Eliaszewicz M; Flahault A; Roujeau JC; Fillet AM; Challine D; Mansouri S; Wolkenstein P; Aractingi S; Penso-Assathiany D; Maslo C; Bourgault-Villada I; Chosidow O; Caumes E;
    J Am Acad Dermatol; 2002 Jul; 47(1):40-6. PubMed ID: 12077579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
    Bandmann O; Vaughan J; Holmans P; Marsden CD; Wood NW
    Lancet; 1997 Oct; 350(9085):1136-9. PubMed ID: 9343502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.